The study of more than two million veterans with diabetes details GLP-1 RA use relating to 175 outcomes; without ...

The good news is that the risk for thyroid cancer linked to GLP-1 drugs appears low, but higher detections in the first year, ...

For patients with diabetes undergoing a surgical procedure, an active perioperative glucagon-like peptide-1 receptor agonist (GLP-1 RA) prescription is associated with reductions in risk-adjusted ...

Websites that sell compounded glucagon-like peptide-1 receptor agonists often partially inform or misinform consumers.

Glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is not associated with an increased risk for thyroid cancer ...

Websites that sell compounded glucagon-like peptide-1 receptor agonists (GLP-1 RAs) often partially inform or misinform ...

By Carissa WongDrugs like Ozempic and Wegovy, called GLP-1 agonists, carry more benefits than risks when taken for their ...

For people with diabetes, the use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) is associated with a reduc ...

With respect to risks, GLP-1RA use was significantly associated with an increased risk of gastrointestinal disorders, hypotension, syncope, arthritic disorders, drug-induced pancreatitis, and other ...

Among GLP-1 RA ever-users, there was no increased risk ... to patients and clinicians about the short-term safety of these drugs,” the authors write. “Nevertheless, evidence was insufficient ...

with and without perioperative prescriptions for GLP-1 RA medications in a retrospective, observational cohort analysis. Patients with type 1 or type 2 diabetes undergoing a surgical procedure ...